Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Correction » MKB

Posted by MKB on November 18, 2004, at 8:21:12

In reply to Re: effexor side effects and suing » Racer, posted by MKB on November 18, 2004, at 7:56:28

I misquoted the Wyeth website. Here is the paragraph from their corporate site.

"EFFEXOR, Wyeth's SNRI (serotonin-norepinephrine reuptake inhibitor) antidepressant achieved worldwide net revenue of $893 million for the third quarter, an increase of 38%. This solid performance continues to be driven by strong clinical data supporting its use in depression and anxiety and its established therapeutic profile with prescribers. Effexor XR remains the first and only once-daily SNRI proven effective in the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder and the long-term prevention of relapse and recurrence of depression. The Effexor franchise is on track to exceed its longstanding goal of $3 billion in annual net revenue in 2004. However, as growth in the antidepressant category is slowing, the growth in Effexor revenues in the 2004 third quarter and first nine months may not be sustained for the balance of the year."


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:MKB thread:416702
URL: http://www.dr-bob.org/babble/20041118/msgs/417361.html